Dr. Catriona Jamieson, MD

Save

Hematology | Female

UC San Diego Health - La Jolla 3855 Health Sciences Drive La Jolla, CA 92093 Get Directions
Dr. Catriona Jamieson, MD

Catriona Jamieson, MD, PhD, is a board-certified hematologist with broad clinical expertise in caring for patients with hematologic malignancies. As hematology team leader for the Division of Hematology/Oncology at UC San Diego Health Moores Cancer Center, Dr. Jamieson’s clinical interests include the treatment of myeloproliferative neoplasms including chronic myeloid leukemia (CML), polycythemia vera (PV), myelofibrosis and essential thrombocythemia. She is also the principal investigator on several clinical trials for the treatment of these and related bone marrow disorders.As a physician-scientist, Dr. Jamieson completed her residency and clinical fellowships in bone marrow transplantation and hematology, as well as a postdoctoral research fellowship in the laboratory of Professor Irving Weissman at Stanford. Together with collaborators, she discovered in 2004 that chronic phase CML is initiated by blood-forming stem cells through expression of the BCR-ABL gene, but that a patient’s transition to the blast crisis stage of CML is driven by myeloid progenitors that have been reprogrammed to behave like leukemia stem cells (LSC) through aberrant activation of the gene beta-catenin (Jamieson et al., The New England Journal of Medicine 2004). In her own laboratory first at Moores Cancer Center, and now also at the Sanford Consortium for Regenerative Medicine, she has expanded this research to include analysis of the events involved in the initiation and progression of a variety of blood cancers.As a principal investigator on several research grants funded by the California Institute for Regenerative Medicine (CIRM), Dr. Jamieson has a deep interest in understanding the mechanisms fueling the development, progression and therapeutic resistance of hematologic malignancies. Her translational research efforts have led to discovery of small molecule therapeutic inhibitors that are now being tested in two Phase 1 clinical trials for two different blood cancers. A successful, recently completed Phase l clinical trial showed promising results for myelofibrosis. The continued aims of her research group focus on developing novel therapeutic strategies for hematological malignancies that will improve the quality of life of people with these disorders, with the goal of developing curative therapies that will obviate therapeutic resistance and disease relapse.

...See Less

Learn about this doctor

Dr. Jamieson's Experience

0ExperienceMatch
Experience Match

See how Dr. Jamieson's experience matches your preferences.

3
Specialties

For the best healthcare for your needs, choose a doctor who specializes in your medical condition.

1
Board Certifications

Board certification indicates that a doctor is highly qualified in the medical field in which they practice.

42
Conditions Treated

Check to see that this provider treats your medical condition.

1
Procedures Performed

Check to see that this provider performs the procedure that you need.

Background Check

Check to see if your provider has any malpractices, board actions, or sanctions.

Education

Learn more about where this provider went to medical school, residency, and more.

Awards & Recognition

View information about special awards and recognition for this provider.

Languages Spoken

Check to see what languages this provider and/or staff speak.

Memberships & Professional Affiliations

View memberships and affiliations associated with this provider.

Visiting Dr. Jamieson

Dr. Jamieson accepts 13 insurance carriers

Dr. Jamieson is now accepting new patients
Moores Cancer Center3855 Health Sciences Drive
La Jolla, CA 92093
This provider offers the following appointment availability:
Same Day
Next Day
(858) 657-7000Get Directions

Affiliated Hospitals

Hospital Quality
Check out the quality of care at the 1 hospitals where Dr. Jamieson has admitting privileges.

Dr. Jamieson's Reviews

Likelihood of recommending Dr. Jamieson to family and friends
5.0
based on 3 total reviews
Dr. Jamieson's Performance
  • Trustworthiness
    EXCELLENT
  • Explains condition(s) well
    EXCELLENT
  • Answers Questions
    EXCELLENT
  • Time well spent
    EXCELLENT
Office & Staff Performance
  • Scheduling
    EXCELLENT
  • Office environment
    EXCELLENT
  • Staff friendliness
    EXCELLENT
  • Average wait time
    Under 10 minutes
Have you seen Dr. Catriona Jamieson, MD?
Are you Dr. Jamieson?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Compare Dr. Jamieson

Compare this Doctor
View other doctors with similar experience to find the right doctor for you.
View all 10 matches

Dr. Jamieson says...

Catriona Jamieson, MD, PhD, is a board-certified hematologist with broad clinical expertise in caring for patients with hematologic malignancies. As hematology team leader for the Division of Hematology/Oncology at UC San Diego Health Moores Cancer Center, Dr. Jamieson’s clinical interests include the treatment of myeloproliferative neoplasms including chronic myeloid leukemia (CML), polycythemia vera (PV), myelofibrosis and essential thrombocythemia. She is also the principal investigator on several clinical trials for the treatment of these and related bone marrow disorders.As a physician-scientist, Dr. Jamieson completed her residency and clinical fellowships in bone marrow transplantation and hematology, as well as a postdoctoral research fellowship in the laboratory of Professor Irving Weissman at Stanford. Together with collaborators, she discovered in 2004 that chronic phase CML is initiated by blood-forming stem cells through expression of the BCR-ABL gene, but that a patient’s transition to the blast crisis stage of CML is driven by myeloid progenitors that have been reprogrammed to behave like leukemia stem cells (LSC) through aberrant activation of the gene beta-catenin (Jamieson et al., The New England Journal of Medicine 2004). In her own laboratory first at Moores Cancer Center, and now also at the Sanford Consortium for Regenerative Medicine, she has expanded this research to include analysis of the events involved in the initiation and progression of a variety of blood cancers.As a principal investigator on several research grants funded by the California Institute for Regenerative Medicine (CIRM), Dr. Jamieson has a deep interest in understanding the mechanisms fueling the development, progression and therapeutic resistance of hematologic malignancies. Her translational research efforts have led to discovery of small molecule therapeutic inhibitors that are now being tested in two Phase 1 clinical trials for two different blood cancers. A successful, recently completed Phase l clinical trial showed promising results for myelofibrosis. The continued aims of her research group focus on developing novel therapeutic strategies for hematological malignancies that will improve the quality of life of people with these disorders, with the goal of developing curative therapies that will obviate therapeutic resistance and disease relapse.

Dr. Jamieson's experience matches your search based on the following criteria:

  •  Based on total number of patients treated over the last 12 months
  •  Specializes in Hematology
  •  Board certified in Hematology
  •  No malpractice claims found
  •  No sanctions found
  •  No board actions found

Awards & Recognition

  • Awards & Honors
    • Healthgrades Honor Roll
    What is a recognized doctor
  • Media & Publications

    Dr. Jamieson has no media or publications listed.

Background Check

  • 0
    Malpractice Claims

    No malpractice history found for California.

    What is medical malpractice
  • 0
    Sanctions

    No sanctions history found for the years that Healthgrades collects data.

    What is a sanction or disciplinary action
  • 0
    Board Actions

    No board actions found for the years that Healthgrades collects data.

    What are board actions

Board Certifications

Why It Matters: Dr. Jamieson's Board Certifications

Board certification should be one of your top considerations when choosing a doctor. Board certification is an official recognition given to doctors who have met specific requirements set by national medical specialty boards in the... More

  • Hematology

Conditions Treated

  • Acute Leukemia
  • Acute Myeloid Leukemia
  • Anemia
  • Antiphospholipid Syndrome (APS)
  • Autoimmune Diseases
  • Bleeding Disorders
  • Blood Disorders
  • Blood Disorders in Pregnancy
  • Bone Cancer
  • Bone Disorders
  • Cancer
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Defects in Pregnancy and Postpartum
  • Coagulation Disorders (incl. Hemophilia)
  • Cryoglobulinemia
  • Deep Vein Thrombosis (DVT)
  • Hemophilia
  • Hemophilia A
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Leukocytosis
  • Lymphocytosis
  • Mast Cell Diseases
  • Myelodysplastic Syndromes
  • Myeloma
  • Myeloproliferative Disorders
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Pancytopenia
  • Polycythemia Rubra Vera
  • Pregnancy-Related Disorders
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Purpura
  • Qualitative Platelet Defects (incl. Glanzmann's Thrombasthenia)
  • Sickle Cell Disease
  • Thalassemia
  • Thrombocytosis
  • Thrombosis
  • Vascular Disease
  • Venous Embolism and Thrombosis

Education

  • Medical School
    University Of British Columbia Faculty Of Medicine

    Graduated in 1995

  • Residency Hospital
    University Of British Columbia
  • Fellowship Hospital
    Stanford University, School Of Medicine

Languages Spoken

  • English
  • Chinese
  • French
  • Russian
  • Spanish

Memberships &
Professional Affiliations

Dr. Jamieson does not have any memberships or affiliations listed. If you are Dr. Jamieson and would like to add memberships or affiliations, please update your free profile.

Specialties

  • Hematology
  • Hematology & Oncology
  • Oncology

Procedures Performed

  • Bone Marrow Biopsy